Razelle Kurzrock, MD (@dr_r_kurzrock) 's Twitter Profile
Razelle Kurzrock, MD

@dr_r_kurzrock

Momx7 (4 children; 3 dogs); wife; Precision/Rare diseases; MCW AD; CMO WIN; physician, not provider; Board CureMetrix/CureMatch (cofounder); opinions mine

ID: 800362127840022528

calendar_today20-11-2016 15:36:16

5,5K Tweet

7,7K Takipçi

5,5K Takip Edilen

Razelle Kurzrock, MD (@dr_r_kurzrock) 's Twitter Profile Photo

Kurzrock axioms Bureaucracy always grows with time. Bureaucracy once established cannot be undone Bureaucracies are always established in order to “improve” a problem Freireich axiom: Every general solution to a specific problem creates new general problems

Brian Van Tine (@bvantine1) 's Twitter Profile Photo

One of the best parts of being an editor at Clinical Cancer Research is that you have the opportunity to nominate someone to write a commentary or write it yourself. This commentary is about trial outcomes in rare tumors #sarcoma #ehe aacrjournals.org/clincancerres/…

Vivek Subbiah, MD (@viveksubbiah) 's Twitter Profile Photo

⭐️Exhilarating discussions on how to move to needle in Rare Cancers in the era of personalized medicine & #PrecisionOncology at Indianapolis Rare Disease Symposium Razelle Kurzrock, MD Dr. Ruemu Birhiray, M.D. Dr. Sumeet Bhatia !

⭐️Exhilarating discussions on how to move to needle in Rare Cancers in the era of personalized medicine &amp; #PrecisionOncology at Indianapolis Rare Disease Symposium  <a href="/Dr_R_Kurzrock/">Razelle Kurzrock, MD</a> <a href="/DrBirhiray/">Dr. Ruemu Birhiray, M.D.</a> Dr. Sumeet Bhatia !
Razelle Kurzrock, MD (@dr_r_kurzrock) 's Twitter Profile Photo

Really enjoyed meeting Dr Ruema Birhiray. Hope we can find ways to collaborate. And it was a pleasure connecting in person again with Vivek!

ESMO - Eur. Oncology (@myesmo) 's Twitter Profile Photo

ESMO announces the publication of the ESMO Tumour-Agnostic Classifier and Screener (ETAC-S), a new framework to assess the tumour-agnostic potential of #CancerTherapies with the aim to optimise the drug development process Annals of Oncology. 🔗ow.ly/rqmR50T6gHt

ESMO announces the publication of the ESMO Tumour-Agnostic Classifier and Screener (ETAC-S), a new framework to assess the tumour-agnostic potential of #CancerTherapies with the aim to optimise the drug development process <a href="/Annals_Oncology/">Annals of Oncology</a>. 
🔗ow.ly/rqmR50T6gHt
OncoDaily (@oncodaily) 's Twitter Profile Photo

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024 Starting from August 26th, Women’s Equality Day in the United States—a day celebrating the 1920 law that granted U.S. women the right to vote — OncoDaily is thrilled to present the 2024

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024

Starting from August 26th, Women’s Equality Day in the United States—a day celebrating the 1920 law that granted U.S. women the right to vote — <a href="/oncodaily/">OncoDaily</a> is thrilled to present the 2024
Erman Akkus (@erman_akkus) 's Twitter Profile Photo

💉Durable stable/partial response to atezo-beva in HCC Journal of Clinical Oncology ❗️✅Significant proportion of HCC tumors become ghost tumors (radiologically persistent without viable tumor cells) ➡️Durable: PR/SD >6 mo ➡️IMbrave150 ✔️CR, PR, SD: 8.9%, 22.1%, 44.2% ✔️77.8% of PRs and 28.5%

💉Durable stable/partial response to atezo-beva in HCC
<a href="/JCO_ASCO/">Journal of Clinical Oncology</a> 

❗️✅Significant proportion of HCC tumors become ghost tumors (radiologically persistent without viable tumor cells)

➡️Durable: PR/SD &gt;6 mo
➡️IMbrave150
✔️CR, PR, SD: 8.9%, 22.1%, 44.2%
✔️77.8% of PRs and 28.5%
Max Wilkinson (@maxewilkinson) 's Twitter Profile Photo

My favourite discovery ever has just come online. Can I please tell you about some seriously wacky molecular biology? The story starts with a reverse transcriptase that SOMEHOW defends bacteria from viruses. (👇 I recommend sound ON for the video 🎹) 1/

The Nobel Prize (@nobelprize) 's Twitter Profile Photo

Do you agree with the mathematical genius John Nash, who received the 1994 prize in economic sciences? His work on game theory can be applied to fields like computing, evolutionary biology and artificial intelligence. Stay tuned as we will announce the 2024 prize this October.

Do you agree with the mathematical genius John Nash, who received the 1994 prize in economic sciences? His work on game theory can be applied to fields like computing, evolutionary biology and artificial intelligence.

Stay tuned as we will announce the 2024 prize this October.
Razelle Kurzrock, MD (@dr_r_kurzrock) 's Twitter Profile Photo

It seems we just crossed the 1,000 peer reviewed publications threshold Big thanks to all my collaborators. I hope we made even a small difference for some of our patients. 🙏🍾🔥

It seems we just crossed the 1,000 peer reviewed publications threshold 
Big thanks to all my collaborators.
I hope we made even a small difference for some of our patients. 
🙏🍾🔥
Jacob J. Adashek, DO (@jacobadashek) 's Twitter Profile Photo

🤩Thrilled to represent🚂The START Center & be a part of this webinar with Melanoma Research Dana Deighton and🎯TargetCancer Fdn🧬about rare🦓cancers - Looking forward to an engaging discussionRegister and submit your questions now! lnkd.in/eyCcmU-U

🤩Thrilled to represent🚂<a href="/TheSTARTCenter/">The START Center</a> &amp; be a part of this webinar with <a href="/MelanomaReAlli/">Melanoma Research</a> <a href="/DanaCdeighton/">Dana Deighton</a> and🎯<a href="/targetcancer/">TargetCancer Fdn</a>🧬about rare🦓cancers - Looking forward to an engaging discussionRegister and submit your questions now! lnkd.in/eyCcmU-U
Razelle Kurzrock, MD (@dr_r_kurzrock) 's Twitter Profile Photo

TRACK: THE national precision genomics trial for rare cancers Fully remote Patient centered home-run trial Our MTB: experts from MCW, Dana Farber, John Hopkins, START, Sarah Cannon, Foundation Medicine, UCSD and more 🔥🎯🎯

TRACK: THE national precision genomics trial for rare cancers 
Fully remote 
Patient centered home-run trial
Our MTB:  experts from MCW, Dana Farber, John Hopkins, START, Sarah Cannon, Foundation Medicine, UCSD and more 
🔥🎯🎯